Cl. Coulter et al., LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55, Brain research, 690(2), 1995, pp. 217-224
Transport into the presynaptic terminal by the dopamine transporter is
the primary mechanism for removing dopamine from the synaptic cleft.
This transporter is a specific marker for dopamine terminals and is a
primary site for CNS actions of cocaine. Several radioligands have bee
n developed for analysis of the dopamine transporter. The ligands vary
in affinity and specificity, leading to differences in reported trans
porter density in brain regions. We compared two of the most commonly
used ligands, [H-3]WIN 35,428 and [I-125]RTI-55, analyzing the localiz
ation and density of sites in the rat brain using serial sections and
quantitative autoradiography. Citalopram at 50 nmol/l was used to bloc
k [I-125]RTI-55 binding to serotonin transport sites. Transporter dens
ity was highest in the striatum and both ligands labeled equivalent nu
mbers of sites, with lateral to medial and anterior to posterior gradi
ents. In most areas the density of sites measured with the two ligands
was similar. However, [I-125]RTI-55 binding was significantly higher
than [H-3]WIN 35,428 binding in the substantia nigra zona compacta, ve
ntral tegmental area, subthalamic nucleus and a number of other subcor
tical nuclear groups while [H-3]WIN 35,428 binding was higher in later
al striatum and in olfactory tubercle. These differences could reflect
different forms of the transporter, perhaps due to post-translational
modifications, and they may provide a basis for differential pharmaco
logical regulation of transporter function in discrete brain regions a
nd disease states.